Medarex, Inc.
MEDX
Medarex, Inc. develops drugs using its UltiMAb technology. Partners with biotech firms on antibody-based drugs for cancer, autoimmune diseases,
allergy/inflammation, and infections. Licensed technology to many drug and biotech companies. The firm is developing a wid...
MEDX is Unavailable
Medarex, Inc. has been flagged in our system as a defunct equity. Most likely, the company has gone private or the stock has been delisted. If you feel this is an error, please contact Piqqem Support
Have something to say?
Register for Piqqem
and give us your take on
Medarex, Inc.
